Cisatracurium

Known as: cisatracurium [Chemical/Ingredient] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
BACKGROUND Reversal of the residual effect of rocuronium or cisatracurium by neostigmine may be slow and associated with side… (More)
  • figure 1
  • table 1
  • table 3
  • figure 2
  • table 4
Is this relevant?
2007
2007
In a randomised, controlled, double-blind, multicentre trial in 338 patients, we assessed the incidence of residual paralysis… (More)
Is this relevant?
2005
2005
General anaesthesia for the patient with a history of anaesthesia-related anaphylaxis is challenging. Precautions against… (More)
Is this relevant?
2004
2004
UNLABELLED With a train-of-four (TOF) ratio >0.70 as the standard of acceptable recovery, postoperative residual paralysis is a… (More)
Is this relevant?
2004
2004
There is conflicting evidence on the duration of action of atracurium in obese patients. Cisatracurium is one of the… (More)
Is this relevant?
2003
2003
PURPOSE Magnesium potentiates the effect of nondepolarizing neuromuscular blocking agents. It is used in cardiac anesthesia to… (More)
Is this relevant?
Review
2002
Review
2002
Laudanosine is a metabolite of the neuromuscular-blocking drugs atracurium and cisatracurium with potentially toxic systemic… (More)
Is this relevant?
2002
2002
BACKGROUND AND OBJECTIVE Monitoring of neuromuscular blockade still often relies on clinical judgement. Moreover, there are… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Because tactile evaluation is the most common form of clinical neuromuscular monitoring, this study examines the… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1996
1996
PURPOSE The primary objective of this study was a blinded, randomized comparison of the recommended intubating dose of atracurium… (More)
Is this relevant?